Back to MW MARSHALL WACE, LLP
EPRX3 quarters
Position history for MWMARSHALL WACE, LLP's holdings in EUPRAXIA PHARMACEUTICALS INC
Yes. Marshall Wace holds 158,133 shares of EPRX (Eupraxia Pharmaceuticals), worth $1M, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. Marshall Wace has held EPRX since Q4 2025, across 3 quarterly 13F filings.
Current Value
$1M
Current Shares
158,133
Total Value Change
-$148,648
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of EPRX: BALYASNY ASSET MANAGEMENT L.P., SCOTIA CAPITAL INC.